YUNG Therapist Sidekick | $825,000 | (Oct 4, 2024)
Rezilient Health | $10,000,000 | (Oct 4, 2024)
kapa.ai | $3,200,000 | (Oct 4, 2024)
Certified by Founder
Lodge
Exeliom Biosciences
start up
France
- Dijon, Bourgogne-Franche-Comté
- 21/07/2023
- Series A
- $8,898,320
At Exeliom Biosciences, we develop single bacterial strain drug candidates to deliver first-in-class microbiome-based therapeutics (also known as Live Biotherapeutics) for the treatment of immune-mediated diseases, with specific focus on inflammatory bowel diseases (IBD), and Crohn’s Disease as a first indication
- Industry Pharmaceutical Manufacturing
- Website https://www.exeliombio.com/
- LinkedIn https://www.linkedin.com/company/nextbiotix/
Related People
Benjamin HadidaFounder
France -
Paris, Île-de-France
Biotech company builder and new therapeutic class explorer
Enara Bio | $32,500,000 | (Oct 4, 2024)
Paren | $3,000,000 | (Oct 4, 2024)
Avarra | $8,000,000 | (Oct 4, 2024)
Sober Sidekick by Empathy Health Tech | $2,800,000 | (Oct 4, 2024)
3Laws | $4,100,000 | (Oct 4, 2024)
Reducto | $8,400,000 | (Oct 4, 2024)
Integrated Biosciences, Inc. | $17,000,000 | (Oct 4, 2024)
Mstack Chemicals | $40,000,000 | (Oct 4, 2024)
FLORA (Flora Fertility) | $1,500,000 | (Oct 4, 2024)
AMAKA Studio | $2,000,000 | (Oct 4, 2024)